All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Relative Articles

More...
PLOS ONE  2013 

Asymptomatic Polyvascular Abnormalities in Community (APAC) Study in China: Objectives, Design and Baseline Characteristics

DOI: 10.1371/journal.pone.0084685

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective The population-based “Asymptomatic Polyvascular Abnormalities in Community (APAC) Study was designed to examine prevalence and associations of asymptomatic polyvascular abnormalities (APA) in a general population. In this report, the objectives, design and baseline data of the APAC study are described. Methods The study included 5,440 participants (40.1% women) with an age of 40+ years who were randomly selected from the population of the Kailuan Study which included 101,510 employees and retirees of the Kailuan Co. Ltd, a large coal mine industry located in Tangshan, Hebei, China. Exclusion criteria were previous cerebral stroke, transient ischemic attacks and coronary heart disease. In 2010 and 2011, information on potential cardiovascular risk factors was collected and all participants underwent transcranial Doppler sonography, measurement of the ankle brachial index, and bilateral carotid duplex sonography. In a first follow-up examination in 2012/2013, retinal photography and spectral-domain optical coherence tomography were additionally performed. In a planned long-term follow-up, data from clinical examinations and laboratory tests and the occurrence of cardiovascular or cerebrovascular events will be collected to build up a predicting model for the risk of ischemic events. Results At baseline, mean age of the participants was 55.2±11.8 years, and men showed a significantly (P<0.001) higher prevalence of arterial hypertension (55.5% vs. 36.5%) and hyperlipidemia (50.7% vs. 46.0%) and a higher blood homocysteine concentration (18.68±10.28μmol/L versus 11.69±6.40μmol/L). Conclusions The APAC is the first study to prospectively evaluate the relationship between intracranial arterial stenosis, retinal nerve fiber layer changes, retinal microvascular signs, and the eventual development of cerebrovascular or cardiovascular events.

References

[1]  Liu M, Wu B, Wang WZ, Lee LM, Zhang SH et al. (2007) Stroke in China: Epidemiology, prevention, and management strategies. Lancet Neurol 6: 456-464. doi:10.1016/S1474-4422(07)70004-2. PubMed: 17434100.
[2]  Gorelick PB, Wong KS, Bae HJ, Pandey DK (2008) Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 39: 2396–2399. doi:10.1161/STROKEAHA.107.505776. PubMed: 18535283.
[3]  Wong LK (2006) Global burden of intracranial atherosclerosis. Int J Stroke 1: 158–159. doi:10.1111/j.1747-4949.2006.00045.x. PubMed: 18706036.
[4]  Sacco RL, Kargman DE, Gu Q, Zamanillo MC (1995) Race ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 26: 14–20. doi:10.1161/01.STR.26.1.14. PubMed: 7839388.
[5]  Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S et al. (2003) From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 108: 1664-1672. doi:10.1161/01.CIR.0000087480.94275.97. PubMed: 14530185.
[6]  Huang HW, Guo MH, Lin RJ, Chen YL, Luo Q et al. (2007) Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi county, Guangdong. Cerebrovasc Dis 24: 111-115. doi:10.1159/000103125. PubMed: 17519553.
[7]  Wong KS, Huang YN, Yang HB, Gao S, Li H et al. (2007) A door-to door survey of intracranial atherosclerosis in Liangbei county, China. Neurology 68: 2031-2034. Available online at: doi:10.1212/01.wnl.0000264426.63544.ee. PubMed: 17548554.
[8]  Wong KS, Ng PW, Tang A, Liu R, Yeung V et al. (2007) Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 68: 2035-2038. doi:10.1212/01.wnl.0000264427.09191.89. PubMed: 17548555.
[9]  Bae HJ, Lee J, Park JM, Kwon O, Koo JS et al. (2007) Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc Dis 24: 355-360. doi:10.1159/000106982. PubMed: 17690548.
[10]  Suri MF, Georgiadis AL, Tariq N, Vazquez G, Qureshi N et al. (2011) Estimated prevalence of acoustic cranial windows and intracranial stenosis in the US elderly population: ultrasound screening in adults for intracranial disease study. Neuroepidemiology 37: 64-71. doi:10.1159/000327757. PubMed: 21860252.
[11]  López-Cancio E, Dorado L, Millán M, Reverté S, Su?ol A et al. (2012) The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: prevalence and risk factors. Atherosclerosis 221: 221-225. doi:10.1016/j.atherosclerosis.2011.12.020. PubMed: 22245037.
[12]  López-Cancio E, Galán A, Dorado L, Jiménez M, Hernández M et al. (2012) Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study. Stroke 43: 2712-2719. doi:10.1161/STROKEAHA.112.661702. PubMed: 22798326.
[13]  Zhang S, Zhou Y, Zhang Y, Gao X, Zhang Q et al. (2013) Prevalence and risk factors of asymptomatic intracranial arterial stenosis in a community-based population of Chinese adults. Eur J Neurol 20: 1479-1485. PubMed: 23746073.
[14]  Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E et al. (2001) Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 358: 1134–1140. PubMed: 11597667.
[15]  Mitchell P, Wang JJ, Wong TY, Smith W, Klein R et al. (2005) Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 65: 1005–1009. Available online at: doi:10.1212/01.wnl.0000179177.15900.ca. PubMed: 16217050.
[16]  Ikram MK, de Jong FJ, Van Dijk EJ, Prins ND, Hofman A et al. (2006) Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain 129: 182-188. PubMed: 16317022.
[17]  Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN et al. (2006) Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 37: 82–86. doi:10.1161/01.STR.0000195134.04355.e5. PubMed: 16306463.
[18]  Xu L, Zhou JQ, Wang S, Wang YX, You QS et al. (2013) Localized retinal nerve fiber layer defects and arterial hypertension. Am J Hypertens 26: 511-517. doi:10.1093/ajh/hps081. PubMed: 23429477.
[19]  Zhao L, Wang YX, Zhang W, Zhang JS, Chen CX et al. (2013) Localized retinal nerve fiber layer defects detected by optical coherence tomography. The Beijing Eye Study. PLOS ONE 8: e68998. doi:10.1371/journal.pone.0068998. PubMed: 23894392.
[20]  Jonas JB, Schiro D (1994) Localized retinal nerve fiber layer defects in nonglaucomatous optic nerve atrophy. Graefes Arch Clin Exp Ophthalmol 232: 759–760. doi:10.1007/BF00184280. PubMed: 7890191.
[21]  Wang YX, Pan Z, Zhao L, You QS, Xu L et al. (2011) Retinal nerve fiber layer thickness. The Beijing Eye Study 2011. PLOS ONE 8: e66763.
[22]  Wu S, Huang Z, Yang X, Zhou Y, Wang A et al. (2012) Prevalence of ideal cardiovascular health and its relationship with the 4- year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes 5: 487–493. doi:10.1161/CIRCOUTCOMES.111.963694. PubMed: 22787064.
[23]  Alexandrov AV, Sloan MA, Wong LK, Douville C, Razumovsky AY et al.. (2007) (207): Practice standards for transcranial Doppler ultrasound: Part I - test performance. J Neuroimaging 17: 11–18. PubMed: 17238867.
[24]  Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R et al. (1999) Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106: 2269–2280. doi:10.1016/S0161-6420(99)90525-0. PubMed: 10599656.
[25]  Hwang JM, Kim TW, Park KH, Kim DM, Kim H (2006) Correlation between topographic profiles of localized retinal nerve fiber layer defects as determined by optical coherence tomography and red-free fundus photography. J Glaucoma 15: 223–228. doi:10.1097/01.ijg.0000212218.96932.f7. PubMed: 16778645.
[26]  Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ et al. (1999) Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 150: 263–270. doi:10.1093/oxfordjournals.aje.a009997. PubMed: 10430230.
[27]  Ye C, To E, Weinreb RN, Yu M, Liu S et al. (2011) Comparison of retinal nerve fiber layer imaging by spectral domain optical coherence tomography and scanning laser ophthalmoscopy. Ophthalmology 118: 2196–2202. doi:10.1016/j.ophtha.2011.03.035. PubMed: 21762989.
[28]  Mitchell P, Wang JJ, Li W, Leeder SR, Smith W (1997) Prevalence of asymptomatic retinal emboli in an Australian urban community. Stroke 28: 63–66. doi:10.1161/01.STR.28.1.63. PubMed: 8996490.
[29]  Hayreh SS (1983) Classification of central retinal vein occlusion. Ophthalmology 90: 458-474. doi:10.1016/S0161-6420(83)34530-9. PubMed: 6877778.
[30]  Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD et al. (2003) Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. Radiology 229: 340-346. doi:10.1148/radiol.2292030516. PubMed: 14500855.
[31]  Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT et al. (2000) Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing group III. Circulation 101: E16-E22. doi:10.1161/01.CIR.101.1.e16. PubMed: 10618318.
[32]  Stroke—1989 ( 1989. ): Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 20 (1407-1431).
[33]  Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T et al. (2005) Lipoprotein-associated phospholipase a2 activity is associated with risk of coronary heart disease and ischemic stroke: The Rotterdam Study. Circulation. 111: 570-575. Available online at: doi:10.1161/01.CIR.0000154553.12214.CD. PubMed: 15699277.
[34]  Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A et al. (2004) Quantifying the heart failure epidemic: Prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam Study. Eur Heart J 25: 1614-1619. doi:10.1016/j.ehj.2004.06.038. PubMed: 15351160.
[35]  Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G et al. (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam Study. Eur Heart J 27: 949-953. PubMed: 16527828.
[36]  Arenillas JF, Candell-Riera J, Romero-Farina G, Molina CA, Chacón P et al. (2005) Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: Associated factors. Stroke 36: 1201-1206. Available online at: doi:10.1161/01.STR.0000166045.12976.af. PubMed: 15879333.
[37]  Hoshino A, Nakamura T, Enomoto S, Kawahito H, Kurata H et al. (2008) Prevalence of coronary artery disease in Japanese patients with cerebral infarction: Impact of metabolic syndrome and intracranial large artery atherosclerosis. Circ J 72: 404-408. doi:10.1253/circj.72.404. PubMed: 18296836.
[38]  Uehara T, Tabuchi M, Mori E (2005) Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Eur J Neurol 12: 218-222. doi:10.1111/j.1468-1331.2004.00959.x. PubMed: 15693812.
[39]  Park KY, Chung CS, Lee KH, Kim GM, Kim YB et al. (2006) Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic korean population. J Clin Neurol 2: 29-33. doi:10.3988/jcn.2006.2.1.29. PubMed: 20396482.
[40]  Elmore EM, Mosquera A, Weinberger J (2003) The prevalence of asymptomatic intracranial large-vessel occlusive disease: The role of diabetes. J Neuroimaging 13: 224-227. doi:10.1177/1051228403013003004. PubMed: 12889168.
[41]  López-Cancio E, Dorado L, Millán M, Reverté S, Su?ol A et al. (2012) The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: prevalence and risk factors. Atherosclerosis 221: 221-225. doi:10.1016/j.atherosclerosis.2011.12.020. PubMed: 22245037.
[42]  Selvin E, Erlinger TP (2004) Prevalence of and risk factors for peripheral arterial disease in the united states: Results from the national health and nutrition examination survey, 1999-2000. Circulation 110: 738-743. doi:10.1161/01.CIR.0000137913.26087.F0. PubMed: 15262830.
[43]  De Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB et al. (2010) Prevalence of asymptomatic carotid artery stenosis in the general population: An individual participant data meta-analysis. Stroke 41: 1294-1297. doi:10.1161/STROKEAHA.110.581058. PubMed: 20431077.
[44]  Wong TY, Hubbard LD, Klein R, Marino EK, Kronmal R et al. (2002) Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol 86: 1007–1013. doi:10.1136/bjo.86.9.1007. PubMed: 12185128.
[45]  Wong TY, Klein R, Nieto FJ, Klein BE, Sharrett AR et al. (2003) Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case–control study. Ophthalmology 110: 933–940. doi:10.1016/S0161-6420(03)00084-8. PubMed: 12750093.
[46]  Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ et al. (1999) Retinal arteriolar diameters and elevated blood pressure: the atherosclerosis risk in communities study. Am J Epidemiol 150: 263-270. doi:10.1093/oxfordjournals.aje.a009997. PubMed: 10430230.
[47]  Wong TY, Mitchell P (2004) Hypertensive retinopathy. N Engl J Med 351: 2310–2317. doi:10.1056/NEJMra032865. PubMed: 15564546.
[48]  Mitchell P, Wang JJ, Smith W (2000) Risk factors and significance of finding asymptomatic retinal emboli. Clin Experiment Ophthalmol 28: 13–17. doi:10.1046/j.1442-9071.2000.00218.x. PubMed: 11345337.
[49]  Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS et al. (2000) Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 20: 1644–1650. doi:10.1161/01.ATV.20.6.1644. PubMed: 10845884.
[50]  Wong TY, Klein R, Sharrett AR, Nieto FJ, Boland LL et al. (2002) Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the atherosclerosis risk in communities study. Stroke 33: 1487–1492. doi:10.1161/01.STR.0000016789.56668.43. PubMed: 12052979.
[51]  Kwa VIH, van der Sande JJ, Stam J, Tijmes N, Vrooland JL (2002) Retinal arterial changes correlate with cerebral small-vessel disease. Neurology 59: 1536-1540. doi:10.1212/01.WNL.0000033093.16450.5C. PubMed: 12451193.
[52]  Schneider R, Rademacher M, Wolf S (1993) Lacunar infarcts and white matter attenuation. Ophthalmologic and microcirculatory aspects of the pathophysiology. Stroke 24: 1874–1879. doi:10.1161/01.STR.24.12.1874. PubMed: 8248970.
[53]  Dozono K, Ishii N, Nishihara Y, Horie A (1991) An autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis. Stroke 22: 993–996. doi:10.1161/01.STR.22.8.993. PubMed: 1866767.
[54]  Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ et al. (2005) Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 206: 319-348. doi:10.1111/j.1469-7580.2005.00395.x. PubMed: 15817102.

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133